Lidoflazine and Propranolol Combination Treatment in Chronic Stable Angina
- Capecitabine. // Reactions Weekly;10/2/2010, Issue 1321, p12
The article describes the case of a 77-year-old woman who took capecitabine for sigmoid andenocarcinoma and later experienced Prinzmetal's angina.
- 755 Combined ultrasound and ECG selection criteria increase the proportion of responders to cardiac resynchronization therapy. Pontillo, D.; Achilli, A.; Sassara, M.; Turreni, F.; Rossi, P.; Achilli, P.; Carluccio, E.; Ambrosio, G. // European Journal of Heart Failure. Supplements;
An abstract of the study "Combined Ultrasound and ECG Selection Criteria Increase the Proportion of Responders to Cardiac Resynchronization Therapy," by D. Pontillo and colleagues is presented.
- cardiotherapy. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p370
A definition of the term "cardiotherapy" which refers to the treatment of heart diseases is presented.
- The `Berlin Heart' assist device. Drews, Thorsen; Loebe, Matthias; Hennig, Ewald; Kaufmann, Friedrich; Muller, Johannes; Hetzer, Roland // Perfusion;Jul2000, Vol. 15 Issue 4, p387
Evaluates the Berlin Heart assist device. System description and implantation; Experience with the device at the Deutsches Herzzentrum Berlin.
- Treat complete heart risk. // Clinical Advisor;Mar2010, Vol. 13 Issue 3, p14
The article discusses the effectiveness of tailoring treatment for patients with heart diseases.
- Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading. Smeeth, Liam; Haines, Andy; Ebrahim, Shah // BMJ: British Medical Journal (International Edition);06/05/99, Vol. 318 Issue 7197, p1548
Presents a study which examined pooled numbers needed to treat derived from trials and meta-analyses of interventions to prevent cardiovascular disease. Effects of treatment with statins; Effects of variation in baseline risk; Implication of clinical setting; Details on the findings of the...
- NOW AVAILABLE. // Drug Topics;4/17/2006, Vol. 150 Issue 8, p66
The article announces the availability of a partial fatty acid oxidation inhibitor, Ranexa (ranolazine extended-release tablets), a medicine that treats chronic angina from Palo Alto, California-based CV Therapeutics. The drug comes in 500-mg strength and is said to prolong the QT interval and...
- Barriers to referral in patients with angina: qualitative study. Gradner, Katy; Chapple, Alison // BMJ: British Medical Journal (International Edition);08/14/99, Vol. 319 Issue 7207, p418
Details a study which explored barriers to patients being referred for possible revascularization. Participants and methods of the study; Fear of hospitals, operations and medical tests; Angina as a chronic illness to be managed or denied; Patients' perception of age and its effect on...
- Personal View. Ross, Alistair // British Medical Journal (Clinical Research Edition);11/7/1987, Vol. 295 Issue 6607, p1204
Relates experiences on the occurrence of mild coronary thrombosis in Great Britain. Use of thrombolytic agent for the treatment of mild coronary thrombosis; Installment of electrocardiography; Importance of a medical consultation in the occurrence of vague chest pains and dyspepsia.